Epitel is a Health Care startup that aims to revolutionize how brain health is monitored. Founded in 2017, the company is headquartered in the United States. Epitel is empowering clinicians, patients, and caregivers who live with and care for neurological disorders through wearables and powerful AI.
The latest milestone for Epitel was the $12.50M Series A investment on 16 February 2022. The investors in this round included Catalyst Health Ventures, Genoa Ventures, Dexcom Ventures, MedMountain Ventures, OSF Healthcare, Wavemaker 360, and SLC Angels.
This significant investment reflects the confidence of prominent venture capital firms in the potential of Epitel's innovative approach to neurological disorder monitoring. With this latest injection of funds, Epitel is well-positioned to further develop and market their wearable devices and AI technologies, making a real impact in the healthcare industry.